Stifel analysts reduced the price target for Danaher Corporation shares (NYSE:DHR) to $260 from the previous target of $265, while maintaining a Hold rating on the stock. The new target sits within ...

Danaher Corporation (NYSE:DHR) stock has experienced a notable downturn, reaching a 52-week low of $225.36. With a market ...

1 Day DHR 1.95% DJIA 0.65% S&P 500 -1.46% Health Care/Life Sciences -0.52% The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing ...

Danaher's Q4 earnings missed expectations due to a decline in its diagnostics segment, despite stronger sales in ...

TD Cowen analyst Dan Brennan lowered the firm’s price target on Danaher (DHR) to $260 from $315 and keeps a Buy rating on the shares. The firm ...

RBC Capital analyst Conor McNamara lowered the firm’s price target on Danaher (DHR) to $277 from $299 but keeps an Outperform rating on the ...

Danaher Corporation DHR reported weaker-than-expected fourth-quarter earnings on Wednesday. The company reported fourth-quarter adjusted earnings per share of $2.14 missing the street view of $2.16.

U.S. stocks slipped after the Federal Reserve held its main interest rate steady and broke a run of cuts that began in ...

Quarterly orders topped estimates, as companies scrambled to get their hands on machinery to make increasingly sophisticated semiconductors. U.S.-listed ASML sto ...

WASHINGTON (AP) — WASHINGTON (AP) — Danaher Corp. (DHR) on Wednesday reported fourth-quarter net income of $1.09 billion. The Washington-based company said it had profit of $1.49 per share. Earnings, ...

This positive outcome has rippled through the industry, with Danaher and Thermo Fisher anticipating their own earnings reports later this week. Analysts have weighed in on Sartorius's results, ...